Evidence map›Paper›PMID 40159347›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Zwitterionic Dipeptide Surface Functionalization of Detonation Nanodiamond for Enhanced Control in Biological Environments.

Elisabeth Mayerhoefer, Himalaya Parajuli, Mihaela-Roxana Cimpan, Daniela Elena Costea, Harsh Nitin Dongre, Anke Krueger

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Millikelvin Intracellular Nanothermometry with Nanodiamonds.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Diamond Chemistry: Advances and Perspectives.Angewandte Chemie (International ed. in English) · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elisabeth MayerhoeferInstitute of Organic Chemistry, University of Stuttgart, Pfaffenwaldring 55, 70569, Stuttgart, Germany.ORCID 0009-0005-4907-1891
Himalaya ParajuliThe Gade Laboratory for Pathology and Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Jonas Lies vei 87, Bergen, 5021, Norway.
Mihaela-Roxana CimpanDepartment of Clinical Dentistry, University of Bergen, Årstadveien 19, Bergen, 5009, Norway.ORCID 0000-0003-2029-3173
Daniela Elena CosteaThe Gade Laboratory for Pathology and Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Jonas Lies vei 87, Bergen, 5021, Norway.ORCID 0000-0001-7673-0358
Harsh Nitin DongreThe Gade Laboratory for Pathology and Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen, Jonas Lies vei 87, Bergen, 5021, Norway.ORCID 0000-0003-4378-2869
Anke KruegerInstitute of Organic Chemistry, University of Stuttgart, Pfaffenwaldring 55, 70569, Stuttgart, Germany.ORCID 0000-0003-3082-4935

Funding

BMBF Cluster4Future QSens FKZ 03ZU1110FEUniversity of Bergen 103015University of Bergen 2022-23
6 · The paper itself

Abstract

Utilizing nanoparticles as innovative theranostic agents for biomedical applications requires full control over the material's properties to dictate their interactions within a biological environment. Owing to its versatile surface chemistry and high biocompatibility, nanodiamond (ND) represents a promising platform for novel healthcare treatments. To ensure the performance and safety of NDs, their properties and behavior must remain unchanged upon administration, a key challenge in nanomedicine. Recently, zwitterionic surface modifications have emerged as new strategies to substantially improve protein-repelling properties and biocompatibility of nanomaterials. Using for the first time covalently conjugated zwitterionic dipeptides as surface modulators for ND particles, we were able to provide a readily accessible, reproducible, and tunable functionalization. The obtained particles demonstrate enhanced colloidal stability and conservation of particle size over a broad pH range and in different protein-containing media compared to the starting material. By simple selection of different dipeptides, we can carefully tailor the biocompatibility and cellular uptake of functionalized NDs. We reveal the functionalized NDs' behavior in biologically relevant 3D organotypic models and how different dipeptide-functionalized NDs interact with squamous epithelium ex vivo. The results pave the way for various applications, e.g., biosensing, tissue engineering or targeted drug delivery of these highly biologically suitable nanoparticles.

Indexed as

DipeptidesNanodiamondsBiocompatible MaterialsHumansParticle SizeSurface PropertiesBiocompatible MaterialsDipeptidesNanodiamondsBiocompatibilityNanoparticlesPeptidesSurface chemistryZwitterions

Identifiers

PMID40159347
PMCPMC12171329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.